Skip to main content
. 2016 Sep 1;6:32421. doi: 10.1038/srep32421

Figure 3. The combination of LASS2 and TGF-β1 exhibited the improved prognostic value for HCC patients in the test cohort.

Figure 3

(A,B). Kaplan-Meier analysis of the correlation between LASS2/TGF-β1 and OS (A) or TTR (B) in the test cohort. GI, LASS2−/TGF-β1−(n = 53); GII, LASS2−/TGF-β1 + (n = 56); GIII, LASS2+/TGF-β1-(n = 16); GIV, LASS2+/TGF-β1 + (n = 59).